June 9, 2009 - AngioScore Inc. said today its flagship product, the AngioSculpt Scoring Balloon Catheter, received approval for the interventional treatment of peripheral artery disease from Japan’s Ministry of Health, Labor and Welfare (MHLW/PMDA).
AngioScore and USCI Japan, a prominent distributor of medical devices in Japan, have collaborated for several years to achieve this milestone. Japan, which is second only to the U.S. in the number of cardiovascular procedures performed globally on an annual basis, represents a major market opportunity for AngioScore.
The company said its AngioSculpt Scoring Balloon Catheter represents the next generation in angioplasty catheters. It uses a nitinol wire element to provide antislipping properties while circumferentially dilating plaque, providing a precise and predictable dilatation across a wide range of lesion types.
For more information: www.angioscore.com